Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000429606 | SCV000521316 | benign | not provided | 2020-03-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24126160, 24082139, 11068149, 22530123, 10213152, 23990795, 26802169, 16621646, 26206375, 24644280) |
Invitae | RCV000429606 | SCV001054495 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000429606 | SCV001151948 | uncertain significance | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001195944 | SCV001366368 | uncertain significance | Alzheimer disease 4 | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The following ACMG criteria were applied in classifying this variant: PS3. |
Ai |
RCV000429606 | SCV002501375 | uncertain significance | not provided | 2021-05-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379036 | SCV002699810 | likely benign | Cardiovascular phenotype | 2020-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |